CRDF
Cardiff Oncology Inc
Price:  
3.59 
USD
Volume:  
1,408,729.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Cardiff EV/EBITDA

-451.6%
Upside

As of 2025-07-03, the EV/EBITDA ratio of Cardiff Oncology Inc (CRDF) is -4.15. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Cardiff's latest enterprise value is 214.75 mil USD. Cardiff's TTM EBITDA according to its financial statements is -51.73 mil USD. Dividing these 2 quantities gives us the above Cardiff EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 11.0x - 13.2x 12.8x
Forward P/E multiples 17.1x - 32.1x 20.6x
Fair Price (12.95) - (9.87) (12.62)
Upside -460.7% - -375.0% -451.6%
3.59 USD
Stock Price
(12.62) USD
Fair Price

Cardiff EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-06-30 -3.59
2025-06-27 -3.59
2025-06-26 -3.60
2025-06-25 -3.52
2025-06-24 -3.65
2025-06-23 -3.60
2025-06-20 -3.52
2025-06-18 -3.42
2025-06-17 -4.29
2025-06-16 -4.50
2025-06-13 -4.43
2025-06-12 -4.41
2025-06-11 -4.50
2025-06-10 -5.06
2025-06-09 -4.50
2025-06-06 -4.52
2025-06-05 -4.19
2025-06-04 -4.19
2025-06-03 -4.05
2025-06-02 -3.84
2025-05-30 -3.92
2025-05-29 -3.83
2025-05-28 -3.64
2025-05-27 -3.52
2025-05-23 -3.43
2025-05-22 -3.24
2025-05-21 -3.26
2025-05-20 -3.48
2025-05-19 -3.28
2025-05-16 -3.15
2025-05-15 -3.07
2025-05-14 -2.97
2025-05-13 -3.03
2025-05-12 -3.07
2025-05-09 -2.96
2025-05-08 -2.92
2025-05-07 -2.74
2025-05-06 -2.81
2025-05-05 -2.98
2025-05-02 -3.16
2025-05-01 -3.02
2025-04-30 -3.06
2025-04-29 -3.11
2025-04-28 -3.33
2025-04-25 -3.24
2025-04-24 -3.26
2025-04-23 -3.32
2025-04-22 -3.46
2025-04-21 -3.16
2025-04-17 -3.20